PRONTERA, CONCETTA
PRONTERA, CONCETTA
Istituto di Fisiologia Clinica - IFC
Health improvements by Understanding Residual Risk In CAd and NEw targets for prevention/treatment: Rationale and Research Protocol of the HURRICANE project
2025 Caselli, Chiara; Occhipinti, Mariaelena; Pane, Katia; De Gori, Carmelo; Rocchiccioli, Silvia; Botto, Nicoletta; Prontera, Concetta; Cavaliere, Carlo; Ragusa, Rosetta; Vecoli, Cecilia; Sansone, Francesco; Passaro, Emanuela; Ceccherini, Elisa; Morlando, Antonio; Clemente, Alberto; Franzese, Monica; Maffei, Erica; Punzo, Bruna; Gimelli, Alessia; Cademartiri, Filippo; Neglia, Danilo
Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects
2017 Vassalle C.; Masotti S.; Lubrano V.; Basta G.; Prontera C.; Di Cecco P.; Del Turco S.; Sabatino L.; Pingitore A.
CONTROLLO DI QUALITÀ IN MEDICINA DI LABORATORIO: STATO DELL'ARTE E POSSIBILI INNOVAZIONI
2010 A. Renieri; S. Giovannini; R. Conte; M. Pierini; A. Pilo; A. Mercuri; M.R. Chiesa; C. Prontera; A. Clerico; G. Zucchelli
Low triiodothyronine and exercise capacity in heart failure
2010 Fontana, M; Passino, C; Poletti, R; Zyw, L; Prontera, C; Scarlattini, M; Clerico, A; Emdin, M; Iervasi, G
Stato dell'arte della misura degli ormoni tiroidei liberi come evidenziato dal Controllo di Qualità Esterno
2010 Giovannini, Stefania; Pilo, Alessandro; Carlo Zucchelli, Gian; Chiesa, MARIA ROSA; Mercuri, Antonella; Renieri, Andrea; Prontera, Concetta; Conte, Raffaele; Scarlattini, Maria; Clerico, Aldo
Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP
2009 Prontera, C; Zucchelli, Gc; Vittorini, S; Storti, S; Emdin, M; Clerico, A
Coronary microvascular impairment is related to increased plasma levels of osteopontin in patients with idiopathic left ventricular dysfunction
2008 Del Ry S.; Maltinti M.; Rizza E.; Prontera C.; Mazzone A. M.; Emdin M.; Giannessi D.; Neglia D.
High molecular weight adiponectin is increased in plasma of patients with idiopathic dilated cardiomyopathy with and without over heart failure.
2008 Giannessi, D; Maltinti, M; Caselli, C; Del Ry, S; Prontera, C; Neglia, D
Increase plasma levels of osteopontin are related with coronary microvascular impairment in patients with idiopathic left ventricular dysfunction.
2008 Del Ry, S; Maltinti, M; Rizza, E; Prontera, C; Mazzone, Am; Emdin, M; Giannessi, D; Neglia, D
LA QUALITÀ ANALITICA DELL'IMMUNOMETRIA: IERI E OGGI
2008 G.C. Zucchelli;A. Pilo; R. Conte; S. Giovannini; A. Mercuri; M.R. Chiesa; C. Prontera; A. Iervasi
Multicentre comparison of BNP andNT-proBNP immunoassays: the CardioOrmocheck study
2008 Prontera, C; Zaninotto, M; Giovannini, S; Zucchelli, G C; Pilo, A; Plebani, M; Sciacovelli, L; Clerico, A
Amino-Terminal Fragment of Pro-Brain Natriuretic Hormone Identifies Functional Impairment and Right Ventricular Overload in Operated Tetralogy of Fallot Patients
2007 Festa, P; Aitali, L; Prontera, C; De Marchi, D; Fontana, M; Emdin, M; Passino, C
Cardiac natriuretic hormones: methodological aspects
2007 Vittorini, S; Prontera, C; Zucchelli, G C; Clerico, A
Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay
2007 Prontera, C; Fortunato, A; Storti, S; Mercuri, A; Longombardo, G; Zucchelli, Gc; Emdin, M; Clerico, A
Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction.
2007 Del Ry, S; Giannessi, D; Maltinti, M; Prontera, C; Iervasi, A; Colotti, C; Emdin, M; L'Abbate, A; Neglia, D
Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure
2007 Vassalle, C; Andreassi, M G; Prontera, C; Fontana, M; Zyw, L; Passino, C; Emdin, M
Osteopontin: a possibile marker of vascular damage
2007 Del Ry, S; Maltinti, M; Colotti, C; Prontera, C; Rizza, E; Mazzone, Am; Emdin, M; Giannessi, D; Neglia, D
Osteopontin: A possible marker of vascular damage.
2007 Del Ry S.; Maltinti M.; Colotti C.; Prontera C.; Rizza E.; Mazzone A.; Emdin M.; Giannessi D.; Neglia D.
RELATIONSHIP BETWEEN CNP AND NT-PROCNP ASSAY IN DISEASES CHARACTERIZED BY ENDOTHELIAL DYSFUNCTION
2007 DEL RY, Silvia; Maltinti, M; Cabiati, M; Prontera, C; Gcatapano, ; Colotti, C; Emdin, M; Giannessi, D
C-type natriuretic peptide increases in patients with idiopathic dilated cardiomyoapathy with or without overt heart failure
2006 Del Ry S.; Maltinti M.; Prontera C.; Iervasi A.; Emdin M.; Daniela G.; Neglia D.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Health improvements by Understanding Residual Risk In CAd and NEw targets for prevention/treatment: Rationale and Research Protocol of the HURRICANE project | 1-gen-2025 | Caselli, Chiara; Occhipinti, Mariaelena; Pane, Katia; De Gori, Carmelo; Rocchiccioli, Silvia; Botto, Nicoletta; Prontera, Concetta; Cavaliere, Carlo; Ragusa, Rosetta; Vecoli, Cecilia; Sansone, Francesco; Passaro, Emanuela; Ceccherini, Elisa; Morlando, Antonio; Clemente, Alberto; Franzese, Monica; Maffei, Erica; Punzo, Bruna; Gimelli, Alessia; Cademartiri, Filippo; Neglia, Danilo | |
Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects | 1-gen-2017 | Vassalle C.; Masotti S.; Lubrano V.; Basta G.; Prontera C.; Di Cecco P.; Del Turco S.; Sabatino L.; Pingitore A. | |
CONTROLLO DI QUALITÀ IN MEDICINA DI LABORATORIO: STATO DELL'ARTE E POSSIBILI INNOVAZIONI | 1-gen-2010 | A. Renieri; S. Giovannini; R. Conte; M. Pierini; A. Pilo; A. Mercuri; M.R. Chiesa; C. Prontera; A. Clerico; G. Zucchelli | |
Low triiodothyronine and exercise capacity in heart failure | 1-gen-2010 | Fontana, M; Passino, C; Poletti, R; Zyw, L; Prontera, C; Scarlattini, M; Clerico, A; Emdin, M; Iervasi, G | |
Stato dell'arte della misura degli ormoni tiroidei liberi come evidenziato dal Controllo di Qualità Esterno | 1-gen-2010 | Giovannini, Stefania; Pilo, Alessandro; Carlo Zucchelli, Gian; Chiesa, MARIA ROSA; Mercuri, Antonella; Renieri, Andrea; Prontera, Concetta; Conte, Raffaele; Scarlattini, Maria; Clerico, Aldo | |
Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP | 1-gen-2009 | Prontera, C; Zucchelli, Gc; Vittorini, S; Storti, S; Emdin, M; Clerico, A | |
Coronary microvascular impairment is related to increased plasma levels of osteopontin in patients with idiopathic left ventricular dysfunction | 1-gen-2008 | Del Ry S.; Maltinti M.; Rizza E.; Prontera C.; Mazzone A. M.; Emdin M.; Giannessi D.; Neglia D. | |
High molecular weight adiponectin is increased in plasma of patients with idiopathic dilated cardiomyopathy with and without over heart failure. | 1-gen-2008 | Giannessi, D; Maltinti, M; Caselli, C; Del Ry, S; Prontera, C; Neglia, D | |
Increase plasma levels of osteopontin are related with coronary microvascular impairment in patients with idiopathic left ventricular dysfunction. | 1-gen-2008 | Del Ry, S; Maltinti, M; Rizza, E; Prontera, C; Mazzone, Am; Emdin, M; Giannessi, D; Neglia, D | |
LA QUALITÀ ANALITICA DELL'IMMUNOMETRIA: IERI E OGGI | 1-gen-2008 | G.C. Zucchelli;A. Pilo; R. Conte; S. Giovannini; A. Mercuri; M.R. Chiesa; C. Prontera; A. Iervasi | |
Multicentre comparison of BNP andNT-proBNP immunoassays: the CardioOrmocheck study | 1-gen-2008 | Prontera, C; Zaninotto, M; Giovannini, S; Zucchelli, G C; Pilo, A; Plebani, M; Sciacovelli, L; Clerico, A | |
Amino-Terminal Fragment of Pro-Brain Natriuretic Hormone Identifies Functional Impairment and Right Ventricular Overload in Operated Tetralogy of Fallot Patients | 1-gen-2007 | Festa, P; Aitali, L; Prontera, C; De Marchi, D; Fontana, M; Emdin, M; Passino, C | |
Cardiac natriuretic hormones: methodological aspects | 1-gen-2007 | Vittorini, S; Prontera, C; Zucchelli, G C; Clerico, A | |
Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay | 1-gen-2007 | Prontera, C; Fortunato, A; Storti, S; Mercuri, A; Longombardo, G; Zucchelli, Gc; Emdin, M; Clerico, A | |
Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction. | 1-gen-2007 | Del Ry, S; Giannessi, D; Maltinti, M; Prontera, C; Iervasi, A; Colotti, C; Emdin, M; L'Abbate, A; Neglia, D | |
Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure | 1-gen-2007 | Vassalle, C; Andreassi, M G; Prontera, C; Fontana, M; Zyw, L; Passino, C; Emdin, M | |
Osteopontin: a possibile marker of vascular damage | 1-gen-2007 | Del Ry, S; Maltinti, M; Colotti, C; Prontera, C; Rizza, E; Mazzone, Am; Emdin, M; Giannessi, D; Neglia, D | |
Osteopontin: A possible marker of vascular damage. | 1-gen-2007 | Del Ry S.; Maltinti M.; Colotti C.; Prontera C.; Rizza E.; Mazzone A.; Emdin M.; Giannessi D.; Neglia D. | |
RELATIONSHIP BETWEEN CNP AND NT-PROCNP ASSAY IN DISEASES CHARACTERIZED BY ENDOTHELIAL DYSFUNCTION | 1-gen-2007 | DEL RY, Silvia; Maltinti, M; Cabiati, M; Prontera, C; Gcatapano, ; Colotti, C; Emdin, M; Giannessi, D | |
C-type natriuretic peptide increases in patients with idiopathic dilated cardiomyoapathy with or without overt heart failure | 1-gen-2006 | Del Ry S.; Maltinti M.; Prontera C.; Iervasi A.; Emdin M.; Daniela G.; Neglia D. |